CLOVER HEALTH INVESTMENTS, CORP. current report, 24 April 2023

Full document

Clover Health Investments, Corp. — Form 8-K Summary

Business Context and Reporting Period

Clover Health filed this Current Report on April 24, 2023, under Item 8.01 to disclose a proposed settlement of the securities class action Bond v. Clover Health Investments, Corp. et al., arising after the Company’s de-SPAC transaction. The filing is not a periodic financial report and does not provide current operating results for a reporting period.

Financial and Liquidity Impact

  • The proposed settlement amount is $22 million, less court-approved fees and expenses awarded to plaintiffs’ counsel.
  • The Company expects $19.5 million of insurance proceeds, either advanced or committed by its insurers, to fund the settlement.
  • The Company expects to fund $2.5 million of settlement costs out of pocket.
  • As of December 31, 2022, the Company had recorded a $500,000 reserve related to the matter.
  • The filing does not provide revenue, profit, cash flow, margin, debt, or total liquidity figures.

Material Changes Versus the Prior Comparable Period

The filing does not present comparative operating or financial results. The principal disclosed change is the April 21, 2023 memorandum of understanding providing for settlement of the securities class action and the April 24, 2023 announcement of that agreement.

Outlook, Risks, Contingencies, and Unusual Items

  • The settlement remains subject to definitive documentation and final court approval; therefore, the litigation may not conclude on the stated terms.
  • The proposed settlement contains no admission of liability or wrongdoing by the Company or other defendants.
  • The expected funding depends in part on the availability and receipt of the stated insurance proceeds.
  • The Company expects customary releases for the defendants if the settlement is completed.
  • The filing’s forward-looking statements regarding the settlement, insurance proceeds, liquidity, operations, and future performance are subject to risks and uncertainties described in the Company’s Form 10-K filed March 1, 2023, and other SEC filings.

Key Facts for Investors to Verify

  • Whether definitive settlement documentation was executed and final court approval was obtained.
  • Whether the $19.5 million of insurance proceeds was received in full and on the expected terms.
  • The final settlement amount, including court-approved plaintiffs’ counsel fees and expenses.
  • The final out-of-pocket cash cost and any adjustment to the $500,000 reserve.
  • The effect of the settlement on subsequent-period liquidity, cash flow, and financial statements.